TOP TIERMARKET NEWSWIRE
News & sentiment

LYELL IMMUNOPHARMA I (LYEL) — News & AI sentiment

LYELL IMMUNOPHARMA I (LYEL) news roundup. 2 stories in the past week, 5 over 30 days. Average 30-day sentiment is 55.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 9 sales totalling $205K — net selling of $205K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 55/100
30d stories
5
avg sentiment 55.8/100
Insider net (90d)
$205K
0 buys · 9 sells
Congress (90d)
0
0 buys · 0 sells

LYEL news in the last 24 hours, 7 days, 30 days and 90 days

How much LYEL coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowLYEL storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days255/100LYEL headlines →
Last 30 days555.8/100LYEL headlines →
Last 90 days1355.1/100LYEL headlines →

Latest stories on LYEL

6d ago
6d ago
Sep 10
Sep 10
Sep 10
Citizens reiterates Lyell Immunopharma stock rating on pipeline progress
Investing.com Analyst Ratings56 · neutralanalyst
Aug 14
Lyell Immunopharma reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 6
Aug 6
Aug 6
Aug 6
Aug 5
Stifel initiates Lyell Immunopharma stock with buy, $44 target
Investing.com Analyst Ratings61 · neutralanalyst
Jul 22
Jun 25
Jun 15
Jun 13
Jun 12
Jun 10
Jun 8
Jun 4
Jun 1
May 23
May 22
Open LYEL in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →